The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction

Jennifer L. Hillman, Lacey J. Lott

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Studies worldwide suggest that the majority of men maintain moderate to high levels of sexual interest throughout their lifespan, but often report some degree of sexual dysfunction. This review is designed to provide essential information regarding erectile dysfunction (ED) and its treatment with Viagra (sildenafil) and other phosphodiesterase-5 (PDE-5) inhibitors such as Levitra and Cialis. The prevalence and aetiology of ED, in comparison to the normal changes associated with ageing, are presented. Misconceptions about Viagra and other PDE-5 inhibitors, as well as these drugs' mechanism of action, clinical efficacy, side-effects, and contraindications are discussed, and the impact of these male enhancement drugs upon sexual partners, their possible use among women, and the influence of extensive product marketing campaigns are addressed. The potential for psychotherapists to assist men (and their partners) with treatment via health education, e-health information, and concurrent sex therapy also is highlighted. The overarching goal is to assist individuals in making informed decisions about the appropriate use of performance enhancing drugs.

Original languageEnglish (US)
Title of host publicationErectile Dysfunction
Subtitle of host publicationCauses, Risk Factors and Management
PublisherNova Science Publishers, Inc.
Pages261-277
Number of pages17
ISBN (Print)9781619423169
StatePublished - Dec 1 2012

Fingerprint

Phosphodiesterase 5 Inhibitors
Erectile Dysfunction
Performance-Enhancing Substances
Sexual Partners
Marketing
Health Education
Psychotherapy
Pharmaceutical Preparations
Decision Making
Therapeutics
Health
Sildenafil Citrate

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hillman, J. L., & Lott, L. J. (2012). The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction. In Erectile Dysfunction: Causes, Risk Factors and Management (pp. 261-277). Nova Science Publishers, Inc..
Hillman, Jennifer L. ; Lott, Lacey J. / The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction. Erectile Dysfunction: Causes, Risk Factors and Management. Nova Science Publishers, Inc., 2012. pp. 261-277
@inbook{31d59d81bccc4171a05adfce1b31030c,
title = "The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction",
abstract = "Studies worldwide suggest that the majority of men maintain moderate to high levels of sexual interest throughout their lifespan, but often report some degree of sexual dysfunction. This review is designed to provide essential information regarding erectile dysfunction (ED) and its treatment with Viagra (sildenafil) and other phosphodiesterase-5 (PDE-5) inhibitors such as Levitra and Cialis. The prevalence and aetiology of ED, in comparison to the normal changes associated with ageing, are presented. Misconceptions about Viagra and other PDE-5 inhibitors, as well as these drugs' mechanism of action, clinical efficacy, side-effects, and contraindications are discussed, and the impact of these male enhancement drugs upon sexual partners, their possible use among women, and the influence of extensive product marketing campaigns are addressed. The potential for psychotherapists to assist men (and their partners) with treatment via health education, e-health information, and concurrent sex therapy also is highlighted. The overarching goal is to assist individuals in making informed decisions about the appropriate use of performance enhancing drugs.",
author = "Hillman, {Jennifer L.} and Lott, {Lacey J.}",
year = "2012",
month = "12",
day = "1",
language = "English (US)",
isbn = "9781619423169",
pages = "261--277",
booktitle = "Erectile Dysfunction",
publisher = "Nova Science Publishers, Inc.",

}

Hillman, JL & Lott, LJ 2012, The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction. in Erectile Dysfunction: Causes, Risk Factors and Management. Nova Science Publishers, Inc., pp. 261-277.

The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction. / Hillman, Jennifer L.; Lott, Lacey J.

Erectile Dysfunction: Causes, Risk Factors and Management. Nova Science Publishers, Inc., 2012. p. 261-277.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction

AU - Hillman, Jennifer L.

AU - Lott, Lacey J.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Studies worldwide suggest that the majority of men maintain moderate to high levels of sexual interest throughout their lifespan, but often report some degree of sexual dysfunction. This review is designed to provide essential information regarding erectile dysfunction (ED) and its treatment with Viagra (sildenafil) and other phosphodiesterase-5 (PDE-5) inhibitors such as Levitra and Cialis. The prevalence and aetiology of ED, in comparison to the normal changes associated with ageing, are presented. Misconceptions about Viagra and other PDE-5 inhibitors, as well as these drugs' mechanism of action, clinical efficacy, side-effects, and contraindications are discussed, and the impact of these male enhancement drugs upon sexual partners, their possible use among women, and the influence of extensive product marketing campaigns are addressed. The potential for psychotherapists to assist men (and their partners) with treatment via health education, e-health information, and concurrent sex therapy also is highlighted. The overarching goal is to assist individuals in making informed decisions about the appropriate use of performance enhancing drugs.

AB - Studies worldwide suggest that the majority of men maintain moderate to high levels of sexual interest throughout their lifespan, but often report some degree of sexual dysfunction. This review is designed to provide essential information regarding erectile dysfunction (ED) and its treatment with Viagra (sildenafil) and other phosphodiesterase-5 (PDE-5) inhibitors such as Levitra and Cialis. The prevalence and aetiology of ED, in comparison to the normal changes associated with ageing, are presented. Misconceptions about Viagra and other PDE-5 inhibitors, as well as these drugs' mechanism of action, clinical efficacy, side-effects, and contraindications are discussed, and the impact of these male enhancement drugs upon sexual partners, their possible use among women, and the influence of extensive product marketing campaigns are addressed. The potential for psychotherapists to assist men (and their partners) with treatment via health education, e-health information, and concurrent sex therapy also is highlighted. The overarching goal is to assist individuals in making informed decisions about the appropriate use of performance enhancing drugs.

UR - http://www.scopus.com/inward/record.url?scp=84895229005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895229005&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84895229005

SN - 9781619423169

SP - 261

EP - 277

BT - Erectile Dysfunction

PB - Nova Science Publishers, Inc.

ER -

Hillman JL, Lott LJ. The potential use and abuse of viagra and other PDE-5 inhibitors for the treatment of erectile dysfunction. In Erectile Dysfunction: Causes, Risk Factors and Management. Nova Science Publishers, Inc. 2012. p. 261-277